Zawada D, Kornherr J, Meier A, Santamaria G, Dorn T, Nowak-Imialek M
Nat Commun. 2023; 14(1):1722.
PMID: 37012244
PMC: 10070453.
DOI: 10.1038/s41467-023-36764-x.
Siatra P, Vatsellas G, Chatzianastasiou A, Balafas E, Manolakou T, Papapetropoulos A
NPJ Regen Med. 2023; 8(1):13.
PMID: 36869039
PMC: 9984483.
DOI: 10.1038/s41536-023-00280-9.
Iop L, Iliceto S, Civieri G, Tona F
Cells. 2021; 10(11).
PMID: 34831398
PMC: 8623957.
DOI: 10.3390/cells10113175.
Wang D, Dong X, Xiong Y, Li Z, Xie Y, Liang S
Am J Med Genet A. 2021; 188(1):58-70.
PMID: 34490705
PMC: 9290998.
DOI: 10.1002/ajmg.a.62488.
Yu M, Kyryachenko S, Debette S, Amouyel P, Schott J, Le Tourneau T
Circ Genom Precis Med. 2021; 14(5):e003148.
PMID: 34461747
PMC: 8530910.
DOI: 10.1161/CIRCGEN.120.003148.
Differential Spatio-Temporal Regulation of T-Box Gene Expression by microRNAs during Cardiac Development.
Alzein M, Lozano-Velasco E, Hernandez-Torres F, Garcia-Padilla C, Dominguez J, Aranega A
J Cardiovasc Dev Dis. 2021; 8(5).
PMID: 34068962
PMC: 8156480.
DOI: 10.3390/jcdd8050056.
Functional analysis of two novel TBX5 variants present in individuals with Holt-Oram syndrome with different clinical manifestations.
Varela D, Varela T, Conceicao N, Ferreira A, Marques N, Paula Silva A
Mol Genet Genomics. 2021; 296(4):809-821.
PMID: 33866394
DOI: 10.1007/s00438-021-01781-2.
A novel TBX5 mutation predisposes to familial cardiac septal defects and atrial fibrillation as well as bicuspid aortic valve.
Jiang W, Xu Y, Zhao C, Wang X, Qiu X, Liu X
Genet Mol Biol. 2020; 43(4):e20200142.
PMID: 33306779
PMC: 7783509.
DOI: 10.1590/1678-4685-GMB-2020-0142.
[A Literature Review on the Role of TBX5 in Expression and Progression of Lung Cancer: Current Perspectives].
Huang W, Li P, Qiu X
Zhongguo Fei Ai Za Zhi. 2020; 23(10):883-888.
PMID: 32810974
PMC: 7583881.
DOI: 10.3779/j.issn.1009-3419.2020.102.27.
TBX5 R264K acts as a modifier to develop dilated cardiomyopathy in mice independently of T-box pathway.
Miyao N, Hata Y, Izumi H, Nagaoka R, Oku Y, Takasaki I
PLoS One. 2020; 15(4):e0227393.
PMID: 32236096
PMC: 7112173.
DOI: 10.1371/journal.pone.0227393.
Cardiac Differentiation of Adipose Tissue-Derived Stem Cells Is Driven by BMP4 and bFGF but Counteracted by 5-Azacytidine and Valproic Acid.
Hasani S, Javeri A, Asadi A, Taha M
Cell J. 2019; 22(3):273-282.
PMID: 31863652
PMC: 6947007.
DOI: 10.22074/cellj.2020.6582.
The role of ESCO2, SALL4 and TBX5 genes in the susceptibility to thalidomide teratogenesis.
Gomes J, Kowalski T, Fraga L, Macedo G, Vieira Sanseverino M, Schuler-Faccini L
Sci Rep. 2019; 9(1):11413.
PMID: 31388035
PMC: 6684595.
DOI: 10.1038/s41598-019-47739-8.
A novel de novo mutation in a patient with Holt-Oram syndrome.
Rios-Serna L, Diaz-Ordonez L, Candelo E, Pachajoa H
Appl Clin Genet. 2018; 11:157-162.
PMID: 30538526
PMC: 6260184.
DOI: 10.2147/TACG.S183418.
Interplay between cardiac transcription factors and non-coding RNAs in predisposing to atrial fibrillation.
Mikhailov A, Torrado M
J Mol Med (Berl). 2018; 96(7):601-610.
PMID: 29754254
DOI: 10.1007/s00109-018-1647-4.
A TBX5 3'UTR variant increases the risk of congenital heart disease in the Han Chinese population.
Wang F, Liu D, Zhang R, Yu L, Zhao J, Yang X
Cell Discov. 2017; 3:17026.
PMID: 28761722
PMC: 5527299.
DOI: 10.1038/celldisc.2017.26.
TBX5: A Key Regulator of Heart Development.
Steimle J, Moskowitz I
Curr Top Dev Biol. 2017; 122:195-221.
PMID: 28057264
PMC: 5371404.
DOI: 10.1016/bs.ctdb.2016.08.008.
Myocardial transcription factors in diastolic dysfunction: clues for model systems and disease.
Mikhailov A, Torrado M
Heart Fail Rev. 2016; 21(6):783-794.
PMID: 27306370
DOI: 10.1007/s10741-016-9569-0.
A genetic assay of three patients in the same family with Holt-Oram syndrome; a case report.
Ebrahimzadeh-Vesal R, Hosseini S, Rezakhanlu F, Derakhshandeh-Peykar P
Rep Biochem Mol Biol. 2016; 2(1):52-5.
PMID: 26989721
PMC: 4757068.
Prevalence and Spectrum of TBX5 Mutation in Patients with Lone Atrial Fibrillation.
Wang Z, Ji W, Ruan C, Liu X, Qiu X, Yuan F
Int J Med Sci. 2016; 13(1):60-7.
PMID: 26917986
PMC: 4747871.
DOI: 10.7150/ijms.13264.
ROCK inhibitor is not required for embryoid body formation from singularized human embryonic stem cells.
Pettinato G, Vanden Berg-Foels W, Zhang N, Wen X
PLoS One. 2014; 9(11):e100742.
PMID: 25365581
PMC: 4217711.
DOI: 10.1371/journal.pone.0100742.